aspirin has been researched along with Stomach Neoplasms in 118 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
Excerpt | Relevance | Reference |
---|---|---|
"We examined the effect of aspirin on survival following resection for squamous cell carcinoma (SCC) of the esophagus or adenocarcinoma of the gastric cardia." | 9.14 | A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. ( Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ, 2009) |
" Overall survival and cancer-specific survival of esophageal, gastric and colorectal cancers among aspirin users were compared with those among non-aspirin users." | 9.05 | Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis. ( Cao, LL; Chen, QY; Huang, CM; Li, P; Lin, JL; Lin, JX; Lin, M; Lu, J; Wang, JB; Xie, JW; Zheng, CH, 2020) |
" We found that regular aspirin use was associated with lower risk of gastric adenocarcinoma among women, but not men." | 8.12 | Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study. ( Bao, Y; Cao, Y; Chan, AT; Drew, DA; Flynn, JJ; Fuchs, CS; Giovannucci, EL; Klempner, SJ; Kwon, S; Leonardo, BM; Ma, W; Song, M, 2022) |
"Low-dose aspirin use may reduce cancer incidence and mortality, but its influence on gastric adenocarcinoma survival is unclear." | 8.12 | Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma. ( Asplund, J; Holmberg, D; Kauppila, JH; Lagergren, J; Leijonmarck, W; Mattsson, F; Xie, SH, 2022) |
"This cohort study with <10 years of follow-up suggests metformin use may not prevent gastric adenocarcinoma." | 7.91 | Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019) |
"To investigate the inhibitory effect of arsenic trioxide, aspirin and their combination on the growth of human gastric adenocarcinoma SGC-7901 graft in nude mice." | 7.75 | [Effect of arsenic trioxide combined with aspirin on the growth of human gastric adenocarcinoma graft in nude mice]. ( Liu, H; Qiu, J; Wu, YP, 2009) |
"Preclinical, epidemiological, and randomised data indicate that aspirin might prevent tumour development and metastasis, leading to reduced cancer mortality, particularly for gastro-oesophageal and colorectal cancer." | 5.30 | Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. ( Adams, R; Berkman, L; Bridgewater, J; Cafferty, F; Cameron, D; Crossley, A; Din, F; Falk, S; Gilbert, D; Graham, J; Gupta, K; Henson, V; Hubner, R; Iveson, T; Jankowski, J; Joharatnam-Hogan, N; Khabra, K; Kunene, V; Kynaston, H; Langley, R; Patel, K; Pramesh, CS; Ring, A; Rowley, S; Sothi, S; Swinson, D; Thomas, A; Underwood, T; Warner, N; Wilson, R, 2019) |
" These occurred only in the groups given MNNG in combination with stress, aspirin, or sodium taurocholate, and did not occur in experimental groups given either MNNG, stress, aspirin, or sodium taurocholate alone, and did not occur in the control group." | 5.27 | Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. ( Cohen, A; Geller, SA; Horowitz, I; Toth, LS; Werther, JL, 1984) |
"We examined the effect of aspirin on survival following resection for squamous cell carcinoma (SCC) of the esophagus or adenocarcinoma of the gastric cardia." | 5.14 | A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. ( Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ, 2009) |
" Overall survival and cancer-specific survival of esophageal, gastric and colorectal cancers among aspirin users were compared with those among non-aspirin users." | 5.05 | Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis. ( Cao, LL; Chen, QY; Huang, CM; Li, P; Lin, JL; Lin, JX; Lin, M; Lu, J; Wang, JB; Xie, JW; Zheng, CH, 2020) |
"Along with the growing elderly population, patients with gastric ulcers caused by low-dose aspirin have increased." | 4.86 | [Differential diagnosis of gastric ulcer and gastric cancer in elderly patients]. ( Akamatsu, T; Arakura, N; Ito, T; Iwaya, Y; Nagaya, T; Suga, T, 2010) |
"Aspirin and other NSAIDs are showing promise in the chemoprevention of colorectal cancer." | 4.80 | Non-steroidal anti-inflammatory drugs and chemoprevention of cancer. ( Morgan, G; Vainio, H, 2000) |
"Replacement of thienopyridine with aspirin or cilostazol may be acceptable for minimizing both the risk of post-ESD bleeding and thromboembolism in patients with EGC." | 4.31 | Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. ( Asahina, Y; Fujishiro, M; Hasatani, K; Hatta, W; Hayashi, Y; Hikichi, T; Hoteya, S; Iguchi, M; Inoue, T; Kikuchi, D; Kiyotoki, S; Kobayashi, M; Kuribayashi, S; Mabe, K; Masamune, A; Matsumura, T; Michida, T; Mikami, T; Miura, Y; Morita, Y; Nagami, Y; Nakamatsu, D; Narasaka, T; Nebiki, H; Nishikawa, J; Ohnita, K; Sugimoto, M; Sumiyoshi, T; Suzuki, H; Tomida, H; Tsuji, S; Tsuji, Y; Ueyama, H; Yabuuchi, Y; Yada, T; Yamaguchi, S; Yoshio, T, 2023) |
" However, among former aspirin users and never smokers, there could be a reduction of gastric distal adenocarcinoma risk with a higher adherence to a Mediterranean diet." | 4.31 | Diet quality and risk of gastric adenocarcinoma: The Multiethnic Cohort. ( Acuna, N; Boushey, C; Hébert, JR; Le Marchand, L; Park, SY; Setiawan, VW; Wilkens, LR; Wu, AH, 2023) |
" We found that regular aspirin use was associated with lower risk of gastric adenocarcinoma among women, but not men." | 4.12 | Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study. ( Bao, Y; Cao, Y; Chan, AT; Drew, DA; Flynn, JJ; Fuchs, CS; Giovannucci, EL; Klempner, SJ; Kwon, S; Leonardo, BM; Ma, W; Song, M, 2022) |
"Low-dose aspirin use may reduce cancer incidence and mortality, but its influence on gastric adenocarcinoma survival is unclear." | 4.12 | Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma. ( Asplund, J; Holmberg, D; Kauppila, JH; Lagergren, J; Leijonmarck, W; Mattsson, F; Xie, SH, 2022) |
"This cohort study with <10 years of follow-up suggests metformin use may not prevent gastric adenocarcinoma." | 3.91 | Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019) |
" We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i." | 3.85 | Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer. ( Das, KM; Fukui, H; Hara, K; Ito, C; Kondo, T; Kono, T; Michigami, Y; Miwa, H; Morimoto, T; Oshima, T; Tomita, T; Tozawa, K; Watari, J; Yamasaki, T, 2017) |
"The aim of this study was to investigate whether aspirin use can reduce the incidence of gastric cancer in patients with hypertension or type 2 diabetes." | 3.83 | Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study. ( Choi, IJ; Kim, JH; Kim, SY; Kim, YI; Kim, YW; Lee, JH; Park, JH; Ryu, KW, 2016) |
"To investigate the inhibitory effect of arsenic trioxide, aspirin and their combination on the growth of human gastric adenocarcinoma SGC-7901 graft in nude mice." | 3.75 | [Effect of arsenic trioxide combined with aspirin on the growth of human gastric adenocarcinoma graft in nude mice]. ( Liu, H; Qiu, J; Wu, YP, 2009) |
"We aimed to explore whether risk of postoperative hemorrhage due to aspirin differs in the East and the West." | 2.82 | The risk of aspirin induced postoperative hemorrhage: a systematic review and meta-analysis. ( Chen, Y; Ding, Z; Han, C; Lin, R; Ling, X; Liu, J; Nie, C; Sheng, L, 2022) |
"The protective effect of statin against gastric cancer was also significant in patients with diabetes mellitus." | 2.82 | Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis. ( Bang, CS; Kim, HH; Kim, J; Kim, JY; Kim, TJ; Lee, KJ; Park, CH; Seo, SI; Shin, WG; You, SC, 2022) |
"Add-Aspirin is a phase III, multi-centre, double-blind, placebo-controlled randomised trial with four parallel cohorts." | 2.82 | ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. ( Berkman, L; Cafferty, FH; Cameron, D; Coyle, C; Gilbert, D; Gupta, S; Kynaston, H; Langley, RE; MacKenzie, M; Pramesh, CS; Ring, A; Rowley, S; Wilson, RH, 2016) |
" The dose-response analysis and subgroup analysis were also performed." | 2.55 | Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis. ( Chen, WJ; Chen, Y; Huang, XZ; Sun, SS; Wu, CC; Wu, J; Zhang, CY; Zhang, X, 2017) |
"Recent studies in esophagogastric cancer help clarify the role of radiation therapy in surgical management, as well as the role of chemotherapeutic and targeted agents." | 2.53 | An update in the nonendoscopic treatment of gastric cancer. ( Ilson, DH, 2016) |
"Inflammation is a non-specific immune response to infection, irritation or other injury, the key features being redness, warmth, swelling and pain." | 2.49 | Immunoinflammatory responses in gastrointestinal tract injury and recovery. ( Alam, MM; Marella, A; Shaquiquzzaman, M; Verma, G, 2013) |
" The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression." | 2.49 | Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis. ( Chen, S; Fu, J; Gao, Y; Liu, L; Yang, Y; Ye, X, 2013) |
" There are now more than 15 epidemiological (case-control and cohort) studies indicating that long-term use of aspirin is associated with a reduced risk of colorectal cancer." | 2.41 | Aspirin and cancer risk: an update to 2001. ( Bosetti, C; Gallus, S; La Vecchia, C, 2002) |
"The relative risk of colorectal cancer is about 0." | 2.41 | Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. ( Sjödahl, R, 2001) |
"Aspirin has been well known for its anti-pyretic and anti-inflammatory action over the past century." | 2.40 | Aspirin induced apoptosis in gastric cancer cells. ( Lam, SK; Wong, BC; Zhu, GH, 1999) |
"Gastric cancer is one of the most common and deadly cancers among men and women and is the third leading cause of cancer mortality worldwide." | 1.62 | Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity. ( Bai, Y; Fan, Y; Li, D; Li, S; Li, Y; Lin, S; Wang, Z; Zhang, S; Zhang, Y, 2021) |
" In conclusion, long-term use of aspirin was independently associated with reduced incidence and mortality of gastric cancer in the general population, but metformin or statin use was only associated with a reduction of gastric cancer mortality in patients with diabetes and in the general population, respectively." | 1.62 | Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study. ( Cho, MH; Jeong, SM; Shin, DW; Yoo, TG, 2021) |
"We identified 727 incident cases of gastric cancer and 1394 incident cases of oesophageal cancer." | 1.56 | Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network. ( Cea Soriano, L; García Rodríguez, LA; Soriano-Gabarró, M; Vora, P, 2020) |
"A total of 597 patients with gastric neoplasms treated with ESD between January 2010 and June 2017 were enrolled." | 1.51 | Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. ( Amano, Y; Harada, H; Hayasaka, K; Katsuyama, Y; Murakami, D; Nagasaka, T; Nakahara, R; Sagami, R; Suehiro, S; Ujihara, T, 2019) |
"The risk of gastric cancer (GC) declines after Helicobacter pylori (H." | 1.51 | DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use. ( Das, KM; Fukui, H; Ito, C; Miwa, H; Oshima, T; Shimoda, T; Tomita, T; Watari, J, 2019) |
"Many studies have found evidence that aspirin has protective effects against certain cancers, but quantitative dose-response data have been available only on a limited basis." | 1.48 | Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer. ( Banerjee, S; Chang, J; Kim, MH; Kim, WJ; Park, SM, 2018) |
"Aspirin use was associated with a reduced GC risk (HR = 0." | 1.48 | Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study. ( Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK, 2018) |
"For in vitro experiments, human gastric cancer cell lines were used to confirm the cancer cell growth and inhibition by reducing the platelet count or using aspirin." | 1.43 | Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study. ( Doki, Y; Kurokawa, Y; Mikami, J; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M, 2016) |
"Epidemiological studies on aspirin and stomach cancer have been inconclusive." | 1.42 | Regular aspirin use and stomach cancer risk in China. ( Duan, H; Ge, J; Shen, C; Wang, Y, 2015) |
"The risk of postoperative hemorrhage following gastric ESD was higher in patients with antithrombotic therapy than in those without that therapy." | 1.39 | The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. ( Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E, 2013) |
"Patients who underwent ESD for early gastric neoplasms at the National Cancer Center Hospital, Korea, between November 2008 and January 2011 were enrolled." | 1.38 | Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. ( Cho, SJ; Choi, IJ; Kim, CG; Kim, HJ; Kim, YW; Kwak, MH; Lee, JH; Lee, JY; Nam, BH; Ryu, KW, 2012) |
"The incidence of esophageal and gastric cancers was high at 5." | 1.36 | Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. ( Kawai, T; Watanabe, M; Yamashina, A, 2010) |
"Aspirin (5 mM) treatment of MKN28 gastric epithelial monolayers significantly decreased transepithelial electrical resistance and increased dextran permeability." | 1.35 | Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. ( Joh, T; Miwa, H; Oshima, T, 2008) |
"Apoptosis in gastric cancer cells expressing wild-type p53 is induced through up-regulation of bax and down-regulation of bcl-2 and that regulation of the bax-bcl-2 heterodimer may be a major target of NSAIDs." | 1.35 | Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells. ( Dai, Q; Li, EL; Shen, GF; Wu, SM; Xiao, SD; Zhang, YJ; Zhu, HY, 2008) |
"First we analyzed 66 gastric cancer samples of Asian and Caucasian patients for the presence of EGFR mutations." | 1.33 | Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer. ( Becker, JC; Berdel, WE; Brandts, C; Domschke, W; Fujimori, T; Ilea, AM; Müller-Tidow, C; Pohle, T; Serve, H; Stolte, M; Tickenbrock, L; Tidow, N, 2006) |
"Proliferation of gastric cancer cell lines treated with octreotide or aspirin was determined by (3)H-thymidine incorporation." | 1.32 | Effects of combined octreotide and aspirin on the growth of gastric cancer. ( Tang, C; Tang, L; Wang, C, 2003) |
"Aspirin could inhibit the AP-1 binding activation stimulated by fetal calf serum." | 1.32 | [Inhibition effect of aspirin on the growth of gastric cancer and the mechanism there-in involved]. ( Tang, C; Wang, C, 2003) |
"pylori-mediated NF-kappaB activation on gastric cancer cells." | 1.31 | H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. ( Akanuma, M; Hirata, Y; Maeda, S; Mitsuno, Y; Ogura, K; Omata, M; Shiratori, Y; Yamaji, Y; Yoshida, H, 2000) |
"A case-control study of stomach cancer which includes 448 cases and 610 hospital controls has been conducted in Moscow, Russia." | 1.30 | Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. ( Borisova, E; Chkhikvadze, V; Maximovitch, D; Zaridze, D, 1999) |
"We have reported reduced risk of fatal colon cancer among persons who used aspirin in a large prospective study." | 1.29 | Aspirin use and risk of fatal cancer. ( Calle, EE; Flanders, WD; Heath, CW; Namboodiri, MM; Thun, MJ, 1993) |
" These occurred only in the groups given MNNG in combination with stress, aspirin, or sodium taurocholate, and did not occur in experimental groups given either MNNG, stress, aspirin, or sodium taurocholate alone, and did not occur in the control group." | 1.27 | Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. ( Cohen, A; Geller, SA; Horowitz, I; Toth, LS; Werther, JL, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (18.64) | 18.7374 |
1990's | 7 (5.93) | 18.2507 |
2000's | 28 (23.73) | 29.6817 |
2010's | 41 (34.75) | 24.3611 |
2020's | 20 (16.95) | 2.80 |
Authors | Studies |
---|---|
Seo, SI | 1 |
Park, CH | 1 |
Kim, TJ | 1 |
Bang, CS | 1 |
Kim, JY | 1 |
Lee, KJ | 1 |
Kim, J | 2 |
Kim, HH | 1 |
You, SC | 1 |
Shin, WG | 2 |
Kwon, S | 1 |
Ma, W | 2 |
Drew, DA | 1 |
Klempner, SJ | 1 |
Leonardo, BM | 1 |
Flynn, JJ | 1 |
Cao, Y | 1 |
Giovannucci, EL | 1 |
Bao, Y | 1 |
Fuchs, CS | 1 |
Song, M | 1 |
Chan, AT | 2 |
Holmberg, D | 1 |
Kauppila, JH | 1 |
Mattsson, F | 1 |
Asplund, J | 1 |
Leijonmarck, W | 1 |
Xie, SH | 2 |
Lagergren, J | 3 |
Umar, A | 1 |
Loomans-Kropp, HA | 1 |
Lai, SW | 1 |
Hwang, BF | 1 |
Liu, CS | 1 |
Liao, KF | 1 |
Ling, X | 1 |
Lin, R | 1 |
Chen, Y | 2 |
Nie, C | 1 |
Sheng, L | 1 |
Liu, J | 1 |
Han, C | 1 |
Ding, Z | 1 |
Miura, Y | 1 |
Tsuji, Y | 2 |
Yoshio, T | 2 |
Hatta, W | 2 |
Yabuuchi, Y | 2 |
Hoteya, S | 2 |
Kikuchi, D | 1 |
Tsuji, S | 2 |
Nagami, Y | 2 |
Hikichi, T | 2 |
Kobayashi, M | 2 |
Morita, Y | 2 |
Sumiyoshi, T | 2 |
Iguchi, M | 2 |
Tomida, H | 2 |
Inoue, T | 2 |
Mikami, T | 2 |
Hasatani, K | 2 |
Nishikawa, J | 2 |
Matsumura, T | 4 |
Nebiki, H | 2 |
Nakamatsu, D | 2 |
Ohnita, K | 2 |
Suzuki, H | 2 |
Ueyama, H | 2 |
Hayashi, Y | 3 |
Sugimoto, M | 2 |
Yamaguchi, S | 2 |
Michida, T | 2 |
Yada, T | 2 |
Asahina, Y | 2 |
Narasaka, T | 2 |
Kuribayashi, S | 2 |
Kiyotoki, S | 2 |
Mabe, K | 2 |
Masamune, A | 2 |
Fujishiro, M | 2 |
Acuna, N | 1 |
Park, SY | 1 |
Le Marchand, L | 1 |
Hébert, JR | 1 |
Boushey, C | 1 |
Wilkens, LR | 2 |
Wu, AH | 1 |
Setiawan, VW | 1 |
Gingold-Belfer, R | 1 |
Issa, N | 1 |
Boltin, D | 1 |
Beloosesky, Y | 1 |
Koren-Morag, N | 1 |
Meyerovitch, J | 1 |
Sharon, E | 1 |
Peleg, N | 1 |
Schmilovitz-Weiss, H | 1 |
Watari, J | 3 |
Ito, C | 2 |
Shimoda, T | 1 |
Tomita, T | 3 |
Oshima, T | 4 |
Fukui, H | 3 |
Das, KM | 2 |
Miwa, H | 4 |
Joharatnam-Hogan, N | 1 |
Cafferty, F | 1 |
Hubner, R | 1 |
Swinson, D | 1 |
Sothi, S | 1 |
Gupta, K | 1 |
Falk, S | 1 |
Patel, K | 1 |
Warner, N | 1 |
Kunene, V | 1 |
Rowley, S | 2 |
Khabra, K | 1 |
Underwood, T | 1 |
Jankowski, J | 1 |
Bridgewater, J | 1 |
Crossley, A | 1 |
Henson, V | 1 |
Berkman, L | 2 |
Gilbert, D | 2 |
Kynaston, H | 2 |
Ring, A | 2 |
Cameron, D | 2 |
Din, F | 1 |
Graham, J | 1 |
Iveson, T | 1 |
Adams, R | 1 |
Thomas, A | 1 |
Wilson, R | 1 |
Pramesh, CS | 2 |
Langley, R | 1 |
Tozawa, K | 2 |
Zheng, J | 1 |
Santoni, G | 1 |
Oura, H | 1 |
Kawasaki, Y | 1 |
Okimoto, K | 2 |
Ishikawa, K | 1 |
Kaneko, T | 1 |
Tokunaga, M | 1 |
Oike, T | 1 |
Imai, Y | 1 |
Yokoyama, Y | 1 |
Akizue, N | 1 |
Maruoka, D | 2 |
Ohta, Y | 1 |
Saito, K | 2 |
Nakagawa, T | 2 |
Arai, M | 2 |
Kato, J | 1 |
Kato, N | 1 |
García Rodríguez, LA | 1 |
Soriano-Gabarró, M | 1 |
Vora, P | 1 |
Cea Soriano, L | 1 |
Meiser, B | 1 |
Kaur, R | 1 |
Kirk, J | 1 |
Morrow, A | 1 |
Peate, M | 1 |
Wong, WKT | 1 |
McPike, E | 1 |
Cops, E | 1 |
Dowson, C | 1 |
Austin, R | 1 |
Fine, M | 1 |
Thrupp, L | 1 |
Ward, R | 1 |
Macrae, F | 1 |
Hiller, JE | 1 |
Trainer, AH | 1 |
Mitchell, G | 1 |
Win, TT | 1 |
Aye, SN | 1 |
Lau Chui Fern, J | 1 |
Ong Fei, C | 1 |
Hamada, K | 1 |
Kanzaki, H | 1 |
Inoue, M | 1 |
Ishiyama, S | 1 |
Yamauchi, K | 1 |
Miyahara, K | 1 |
Toyokawa, T | 1 |
Tsuzuki, T | 1 |
Miyaike, J | 1 |
Matsubara, M | 1 |
Takahashi, S | 1 |
Nishimura, M | 1 |
Takenaka, R | 1 |
Yunoki, N | 1 |
Hori, S | 1 |
Kobayashi, S | 1 |
Yamasaki, Y | 1 |
Kawahara, Y | 1 |
Ishikawa, H | 1 |
Okada, H | 1 |
Lin, JL | 1 |
Lin, JX | 1 |
Zheng, CH | 1 |
Li, P | 1 |
Xie, JW | 1 |
Wang, JB | 1 |
Lu, J | 1 |
Chen, QY | 1 |
Cao, LL | 1 |
Lin, M | 1 |
Huang, CM | 1 |
Cho, MH | 1 |
Yoo, TG | 1 |
Jeong, SM | 1 |
Shin, DW | 1 |
Lin, S | 1 |
Zhang, Y | 1 |
Wang, Z | 1 |
Zhang, S | 1 |
Li, Y | 1 |
Fan, Y | 1 |
Li, D | 1 |
Li, S | 1 |
Bai, Y | 1 |
Shiroma, S | 1 |
Fujisaki, J | 1 |
Michigami, Y | 1 |
Hara, K | 1 |
Yamasaki, T | 1 |
Kondo, T | 1 |
Kono, T | 1 |
Morimoto, T | 1 |
Brusselaers, N | 1 |
Wahlin, K | 1 |
Engstrand, L | 2 |
Spence, AD | 1 |
Busby, J | 1 |
Johnston, BT | 1 |
Baron, JA | 1 |
Hughes, CM | 1 |
Coleman, HG | 1 |
Cardwell, CR | 1 |
Cheung, KS | 1 |
Chan, EW | 1 |
Wong, AYS | 1 |
Chen, L | 1 |
Seto, WK | 1 |
Wong, ICK | 1 |
Leung, WK | 1 |
Oh, S | 1 |
Kim, SG | 2 |
Choi, JM | 1 |
Lim, JH | 1 |
Yang, HJ | 1 |
Park, JY | 1 |
Han, SJ | 1 |
Kim, JL | 1 |
Chung, H | 1 |
Jung, HC | 1 |
Kim, MH | 2 |
Chang, J | 2 |
Kim, WJ | 2 |
Banerjee, S | 2 |
Park, SM | 2 |
So, S | 1 |
Ahn, JY | 1 |
Kim, N | 1 |
Na, HK | 1 |
Jung, KW | 1 |
Lee, JH | 3 |
Kim, DH | 1 |
Choi, KD | 1 |
Song, HJ | 1 |
Lee, GH | 1 |
Jung, HY | 1 |
Horikawa, Y | 1 |
Mizutamari, H | 1 |
Mimori, N | 1 |
Kato, Y | 1 |
Sawaguchi, M | 1 |
Fushimi, S | 1 |
Sato, S | 1 |
Okubo, S | 1 |
Harada, H | 1 |
Suehiro, S | 1 |
Murakami, D | 1 |
Nakahara, R | 1 |
Nagasaka, T | 1 |
Ujihara, T | 1 |
Sagami, R | 1 |
Katsuyama, Y | 1 |
Hayasaka, K | 1 |
Amano, Y | 1 |
Shah, S | 1 |
Pocard, M | 1 |
Mirshahi, M | 1 |
Tan, VP | 1 |
Wong, BC | 6 |
Verma, G | 1 |
Marella, A | 1 |
Shaquiquzzaman, M | 1 |
Alam, MM | 1 |
Ye, X | 1 |
Fu, J | 1 |
Yang, Y | 2 |
Gao, Y | 1 |
Liu, L | 1 |
Chen, S | 1 |
Jung, HK | 1 |
Lee, HL | 1 |
Jang, JY | 1 |
Lee, H | 1 |
Kim, CG | 2 |
Shin, ES | 1 |
Lee, YC | 3 |
Takeuchi, T | 1 |
Ota, K | 1 |
Harada, S | 1 |
Edogawa, S | 1 |
Kojima, Y | 1 |
Tokioka, S | 1 |
Umegaki, E | 1 |
Higuchi, K | 1 |
Sanomura, Y | 1 |
Oka, S | 1 |
Tanaka, S | 1 |
Numata, N | 1 |
Higashiyama, M | 1 |
Kanao, H | 1 |
Yoshida, S | 1 |
Ueno, Y | 1 |
Chayama, K | 1 |
Peura, DA | 1 |
Wilcox, CM | 1 |
Minemura, S | 1 |
Ishigami, H | 1 |
Katsuno, T | 1 |
Yokosuka, O | 1 |
Wang, Y | 1 |
Shen, C | 1 |
Ge, J | 1 |
Duan, H | 1 |
Kim, YI | 1 |
Kim, SY | 1 |
Kim, JH | 2 |
Kim, YW | 2 |
Ryu, KW | 2 |
Park, JH | 1 |
Choi, IJ | 2 |
Nelson, N | 1 |
Mikami, J | 1 |
Kurokawa, Y | 2 |
Takahashi, T | 1 |
Miyazaki, Y | 1 |
Yamasaki, M | 1 |
Miyata, H | 1 |
Nakajima, K | 1 |
Takiguchi, S | 1 |
Mori, M | 1 |
Doki, Y | 1 |
Ilson, DH | 1 |
Coyle, C | 1 |
Cafferty, FH | 1 |
MacKenzie, M | 1 |
Gupta, S | 1 |
Wilson, RH | 1 |
Langley, RE | 1 |
Huang, XZ | 1 |
Wu, J | 1 |
Zhang, X | 1 |
Wu, CC | 1 |
Zhang, CY | 1 |
Sun, SS | 1 |
Chen, WJ | 1 |
Leung, AM | 1 |
Redlak, MJ | 4 |
Miller, TA | 4 |
Joh, T | 1 |
Zhang, YJ | 1 |
Dai, Q | 1 |
Wu, SM | 1 |
Zhu, HY | 1 |
Shen, GF | 1 |
Li, EL | 1 |
Xiao, SD | 1 |
Bazuro, GE | 1 |
Torino, F | 1 |
Gasparini, G | 1 |
Capurso, L | 1 |
Tahara, T | 1 |
Shibata, T | 1 |
Nakamura, M | 1 |
Yamashita, H | 1 |
Yoshioka, D | 1 |
Okubo, M | 1 |
Maruyama, N | 1 |
Kamano, T | 1 |
Kamiya, Y | 1 |
Fujita, H | 1 |
Nagasaka, M | 1 |
Iwata, M | 1 |
Takahama, K | 1 |
Watanabe, M | 2 |
Hirata, I | 1 |
Arisawa, T | 1 |
Liu, JF | 1 |
Jamieson, GG | 1 |
Wu, TC | 1 |
Zhu, GJ | 1 |
Drew, PA | 1 |
Epplein, M | 1 |
Nomura, AM | 1 |
Henderson, BE | 1 |
Kolonel, LN | 1 |
Yang, P | 1 |
Zhou, Y | 1 |
Chen, B | 1 |
Wan, HW | 1 |
Jia, GQ | 1 |
Bai, HL | 1 |
Wu, XT | 1 |
Qiu, J | 1 |
Wu, YP | 1 |
Liu, H | 1 |
Vieth, M | 1 |
Görgens, D | 1 |
Langner, C | 1 |
Kawai, T | 1 |
Yamashina, A | 1 |
Wang, AY | 1 |
Emura, F | 1 |
Oda, I | 1 |
Cox, DG | 1 |
Kim, HS | 1 |
Yeaton, P | 1 |
Bertuccio, P | 1 |
Bravi, F | 1 |
Bosetti, C | 2 |
Negri, E | 1 |
La Vecchia, C | 2 |
Iwaya, Y | 1 |
Akamatsu, T | 1 |
Ito, T | 1 |
Nagaya, T | 1 |
Suga, T | 1 |
Arakura, N | 1 |
Bor, S | 1 |
Dağli, U | 1 |
Sarer, B | 1 |
Gürel, S | 1 |
Tözün, N | 1 |
Sıvrı, B | 1 |
Akbaş, T | 1 |
Sahın, B | 1 |
Memık, F | 1 |
Batur, Y | 1 |
Wong, CC | 1 |
Cheng, KW | 1 |
Xie, G | 1 |
Zhou, D | 1 |
Zhu, CH | 1 |
Constantinides, PP | 1 |
Rigas, B | 1 |
Dinis-Ribeiro, M | 1 |
Pimentel-Nunes, P | 1 |
Cho, SJ | 1 |
Lee, JY | 1 |
Nam, BH | 1 |
Kwak, MH | 1 |
Kim, HJ | 1 |
Gallus, S | 1 |
Wepner, U | 1 |
Jiang, Xh | 1 |
Fan, XM | 2 |
Lin, MC | 3 |
Jiang, SH | 1 |
Lam, SK | 5 |
Kung, HF | 3 |
Tang, C | 2 |
Wang, C | 2 |
Tang, L | 1 |
SAPISOCHIN, E | 1 |
Becker, JC | 2 |
Grosser, N | 1 |
Boknik, P | 1 |
Schröder, H | 1 |
Domschke, W | 2 |
Pohle, T | 2 |
Shimada, T | 1 |
Koitabashi, A | 1 |
Fujii, Y | 1 |
Hashimoto, T | 1 |
Hosaka, K | 1 |
Tabei, K | 1 |
Namatame, T | 1 |
Yoneda, M | 1 |
Hiraishi, H | 1 |
Terano, A | 1 |
Koop, H | 1 |
Power, JJ | 3 |
Dennis, MS | 1 |
Gu, Q | 1 |
Wang, JD | 1 |
Xia, HH | 1 |
He, H | 1 |
Zou, B | 1 |
Tu, SP | 1 |
Liu, XG | 1 |
Wong, WM | 1 |
Chan, AO | 1 |
Yuen, MF | 1 |
Hwang, HJ | 1 |
Youn, YH | 1 |
Chung, JB | 1 |
Müller-Tidow, C | 1 |
Stolte, M | 1 |
Fujimori, T | 1 |
Tidow, N | 1 |
Ilea, AM | 1 |
Brandts, C | 1 |
Tickenbrock, L | 1 |
Serve, H | 1 |
Berdel, WE | 1 |
Jiménez, P | 1 |
García, A | 1 |
Santander, S | 1 |
Piazuelo, E | 1 |
Takahashi, M | 1 |
Kokubo, T | 1 |
Furukawa, F | 1 |
Chang, TH | 1 |
Lee, KY | 1 |
Sun, CH | 1 |
Chang, YP | 1 |
Murasaki, G | 2 |
Zenser, TV | 1 |
Davis, BB | 1 |
Cohen, SM | 2 |
Cohen, A | 1 |
Geller, SA | 1 |
Horowitz, I | 1 |
Toth, LS | 1 |
Werther, JL | 1 |
Hasegawa, R | 1 |
St John, M | 1 |
Fukushima, S | 1 |
Booker, JA | 1 |
Ito, S | 1 |
Hirono, S | 1 |
Vasquez, TE | 1 |
Bridges, RL | 1 |
Braunstein, P | 1 |
Jansholt, AL | 1 |
Meshkinpour, H | 1 |
Bahari, HM | 1 |
Ross, IN | 1 |
Turnberg, LA | 1 |
Denizot, Y | 1 |
Najid, A | 1 |
Rigaud, M | 1 |
Thun, MJ | 1 |
Namboodiri, MM | 1 |
Calle, EE | 1 |
Flanders, WD | 1 |
Heath, CW | 1 |
Farrow, DC | 1 |
Vaughan, TL | 1 |
Hansten, PD | 1 |
Stanford, JL | 1 |
Risch, HA | 1 |
Gammon, MD | 1 |
Chow, WH | 1 |
Dubrow, R | 1 |
Ahsan, H | 1 |
Mayne, ST | 1 |
Schoenberg, JB | 1 |
West, AB | 1 |
Rotterdam, H | 1 |
Fraumeni, JF | 1 |
Blot, WJ | 1 |
Zhu, GH | 2 |
Eggo, MC | 1 |
Ching, CK | 1 |
Yuen, ST | 1 |
Chan, EY | 1 |
Lai, KC | 1 |
Zaridze, D | 1 |
Borisova, E | 1 |
Maximovitch, D | 1 |
Chkhikvadze, V | 1 |
Yamamoto, H | 1 |
Itoh, F | 1 |
Fukushima, H | 1 |
Hinoda, Y | 1 |
Imai, K | 1 |
Maeda, S | 1 |
Yoshida, H | 1 |
Ogura, K | 1 |
Mitsuno, Y | 1 |
Hirata, Y | 1 |
Yamaji, Y | 1 |
Akanuma, M | 1 |
Shiratori, Y | 1 |
Omata, M | 1 |
Vainio, H | 1 |
Morgan, G | 1 |
Akre, K | 2 |
Signorello, LB | 2 |
Bergström, R | 1 |
Larsson, S | 1 |
Eriksson, BI | 1 |
Nyrén, O | 2 |
Sjödahl, R | 1 |
Ekström, AM | 1 |
Hansson, LE | 1 |
Zhou, XM | 1 |
Zhang, HB | 1 |
Fan, DM | 1 |
Dorofeev, GI | 1 |
Ivashkin, VT | 1 |
Kuznetsov, VV | 1 |
Tkachenko, EI | 1 |
Floate, DA | 1 |
Duggan, JM | 2 |
Stalnikowicz, R | 1 |
Eliakim, R | 1 |
Ligumsky, M | 1 |
Rachmilewitz, D | 1 |
Hegarty, MM | 1 |
Grime, RT | 1 |
Schofield, PF | 1 |
Din, NA | 1 |
Lightdale, CJ | 1 |
Kurtz, RC | 1 |
Boyle, CC | 1 |
Sherlock, P | 1 |
Winawer, SJ | 1 |
Ivey, KJ | 1 |
Hansky, J | 1 |
Allmand, F | 1 |
Mouchet, A | 1 |
Marquand, J | 1 |
Guivarc'h, M | 1 |
Berlinski, M | 1 |
Gillies, M | 1 |
Skyring, A | 1 |
Drèze, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Barrett's Esophagus Study (BEST) Trial - a Multi-Center and Endoscopic Outcomes Project[NCT00586404] | 1,250 participants (Actual) | Observational | 2007-11-30 | Terminated (stopped due to lack of enrollment) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
21 reviews available for aspirin and Stomach Neoplasms
Article | Year |
---|---|
Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.
Topics: Aspirin; Cohort Studies; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2022 |
The risk of aspirin induced postoperative hemorrhage: a systematic review and meta-analysis.
Topics: Aspirin; Endoscopic Mucosal Resection; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Platelet | 2022 |
Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
Topics: Aspirin; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Inf | 2020 |
Aspirin and Reducing Risk of Gastric Cancer: Systematic Review and Meta-Analysis of the Observational Studies.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Duration of Therapy; Humans; P | 2020 |
Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Esophageal Neoplasms; Humans | 2020 |
Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Databases, Factual; Engla | 2018 |
Gastric cancer chemoprevention: the current evidence.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors | 2013 |
Immunoinflammatory responses in gastrointestinal tract injury and recovery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Biogenic Polyamines; Biomarkers; Cyc | 2013 |
Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Publication Bias; Regression Analysis; Ris | 2013 |
Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
Topics: Aspirin; Barrett Esophagus; Cardiovascular Diseases; Colorectal Neoplasms; Drug Combinations; Gastro | 2014 |
An update in the nonendoscopic treatment of gastric cancer.
Topics: Anticarcinogenic Agents; Aspirin; Chemotherapy, Adjuvant; Esophagogastric Junction; Gastrectomy; Hum | 2016 |
Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardia; Dose-Response Relationship, Drug; Female; | 2017 |
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; ErbB Recepto | 2008 |
Aspirin use and the risk of gastric cancer: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Chi-Square Distribution; | 2010 |
[Differential diagnosis of gastric ulcer and gastric cancer in elderly patients].
Topics: Aged; Aspirin; Diagnosis, Differential; Humans; Stomach Neoplasms; Stomach Ulcer | 2010 |
Aspirin and cancer risk: an update to 2001.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Case-Control Studies; Cohort Stu | 2002 |
Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
Topics: Adenocarcinoma; Anticarcinogenic Agents; Aspirin; Cardiovascular Diseases; Cell Transformation, Neop | 2007 |
Aspirin induced apoptosis in gastric cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Hum | 1999 |
Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta Carotene; Case-Control Studie | 2000 |
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colorectal Neopl | 2001 |
Gastritis.
Topics: Animals; Aspirin; Atropine; Bile Acids and Salts; Cell Membrane Permeability; Ethanol; Gastric Juice | 1974 |
3 trials available for aspirin and Stomach Neoplasms
Article | Year |
---|---|
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Colorectal Neoplasms; Combined Modality Ther | 2019 |
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Chemotherapy, Adjuvant; Colorect | 2016 |
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Squamous C | 2009 |
94 other studies available for aspirin and Stomach Neoplasms
Article | Year |
---|---|
Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies; Humans; | 2022 |
Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma.
Topics: Adenocarcinoma; Aspirin; Cohort Studies; Gastrectomy; Humans; Neoplasm Staging; Stomach Neoplasms | 2022 |
Role of Aspirin in Gastric Cancer Prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Female; Gastrointestinal Neoplas | 2022 |
Aspirin Use and Gastric Adenocarcinoma-Letter.
Topics: Adenocarcinoma; Aspirin; Gastric Mucosa; Humans; Stomach Neoplasms | 2022 |
Aspirin Use and Gastric Adenocarcinoma-Reply.
Topics: Adenocarcinoma; Aspirin; Gastric Mucosa; Humans; Stomach Neoplasms | 2022 |
Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.
Topics: Aspirin; Cilostazol; Endoscopic Mucosal Resection; Gastric Mucosa; Gastrointestinal Hemorrhage; Gast | 2023 |
Diet quality and risk of gastric adenocarcinoma: The Multiethnic Cohort.
Topics: Adenocarcinoma; Aspirin; Cohort Studies; Diet; Diet, Mediterranean; Humans; Risk Factors; Stomach Ne | 2023 |
Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Omeprazole; Risk; Stomach Neoplasms | 2023 |
DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use.
Topics: Aged; Aspirin; Cohort Studies; DNA Methylation; Female; Gastric Mucosa; Gene Silencing; Helicobacter | 2019 |
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus; Fe | 2019 |
Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Gastroscopy; Helicobacter Infections; Histamine H2 Antagon | 2020 |
Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2020 |
Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
Topics: Adult; Anticarcinogenic Agents; Aspirin; Colonoscopy; Colorectal Neoplasms; Colorectal Neoplasms, He | 2020 |
Continued Aspirin Treatment May Be a Risk Factor of Delayed Bleeding after Gastric Endoscopic Submucosal Dissection under Heparin Replacement: A Retrospective Multicenter Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Female; Heparin; Hum | 2020 |
Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Topics: Adult; Aged; Aspirin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Mal | 2021 |
Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cyclooxygenase 1; Cyclo | 2021 |
Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan.
Topics: Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Fibrinolytic Agents; Gastric Mucosa; Humans; | 2021 |
Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; CpG | 2017 |
Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Gastro | 2017 |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Topics: Adult; Aged; Aspirin; Chemoprevention; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Fe | 2018 |
Continuous Use of Thienopyridine May Be as Safe as Low-Dose Aspirin in Endoscopic Resection of Gastric Tumors.
Topics: Aged; Aged, 80 and over; Aspirin; Drug Administration Schedule; Endoscopic Mucosal Resection; Female | 2018 |
Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Dose-Response Relatio | 2018 |
Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Case-Control Studies; Deprescriptions; Endoscopic Muco | 2019 |
Effect of Continued Administration of Low-dose Aspirin for Intraoperative Bleeding Control in Gastric Endoscopic Submucosal Dissection.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Case-Control Studies; Endoscopic Muco | 2019 |
Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopic Mucosal Resection; Feasibility Studies; Fe | 2019 |
Response to He et al.
Topics: Aspirin; Humans; Stomach Neoplasms | 2019 |
Targeting the differentiation of gastric cancer cells (KATO‑III) downregulates epithelial‑mesenchymal and cancer stem cell markers.
Topics: Apoptosis; Aspirin; Biomarkers, Tumor; Cell Cycle; Cell Differentiation; Cell Movement; Cell Prolife | 2019 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal | 2013 |
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidog | 2013 |
Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer.
Topics: Aged; Aged, 80 and over; Aspirin; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; G | 2014 |
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents.
Topics: Adenocarcinoma; Aged; Aspirin; Dissection; Female; Fibrinolytic Agents; Gastric Mucosa; Gastroscopy; | 2014 |
Regular aspirin use and stomach cancer risk in China.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Case-Control Studies; China; Fema | 2015 |
Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study.
Topics: Adult; Aged; Aspirin; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypert | 2016 |
On Trial: Evidence From Using Aspirin to Prevent Cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Clinical Trials as | 2015 |
Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Blood Platelets; Cell Prolifer | 2016 |
[75h birthday of D. G. Zaridze].
Topics: Anticarcinogenic Agents; Aspirin; Authorship; Carcinogens; History, 20th Century; History, 21st Cent | 2015 |
Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Inducing Factor; Aspir | 2009 |
Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Claudins; Dextrans; Dose-Response | 2008 |
Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; bcl-2-Associated | 2008 |
Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antigens, CD; Aspirin; Cadherins; | 2010 |
Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female | 2009 |
[Effect of arsenic trioxide combined with aspirin on the growth of human gastric adenocarcinoma graft in nude mice].
Topics: Adenocarcinoma; Animals; Arsenic Trioxide; Arsenicals; Aspirin; bcl-2-Associated X Protein; Humans; | 2009 |
[Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis].
Topics: Aspirin; Carcinoma; Diagnosis, Differential; Gastritis; Helicobacter Infections; Humans; Intestinal | 2010 |
Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study.
Topics: Aged; Aspirin; Cardiovascular Agents; Duodenal Ulcer; Endoscopy, Digestive System; Esophageal Neopla | 2010 |
Endoscopic submucosal dissection with electrosurgical knives in a patient on aspirin therapy (with video).
Topics: Aged; Aspirin; Dissection; Electrosurgery; Female; Gastric Mucosa; Humans; Platelet Aggregation Inhi | 2010 |
Aspirin and gastric cancer risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Case-Control Studies; Hum | 2010 |
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Endoscopy, Gastrointestinal; Fe | 2011 |
Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carboxylesterase; Carboxylic Ester Hydrol | 2012 |
Should antiplatelets be stopped before gastric mucosectomy? For how long and in whom?
Topics: Aspirin; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Male; Platelet Ag | 2012 |
Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms.
Topics: Adenocarcinoma; Adenoma; Aged; Aspirin; Cardiovascular Diseases; Female; Gastric Mucosa; Gastrointes | 2012 |
[A case for proton pump blocker... When cough comes from the stomach].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age | 2002 |
Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; As | 2003 |
Effects of combined octreotide and aspirin on the growth of gastric cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Humans; Male; Mice; Mice, Inbred B | 2003 |
[Inhibition effect of aspirin on the growth of gastric cancer and the mechanism there-in involved].
Topics: Adenocarcinoma; Aspirin; Cell Division; Cyclooxygenase 2; Humans; Isoenzymes; Membrane Proteins; Pro | 2003 |
[ACUTE DIGESTIVE HEMORRHAGES].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Aspirin; Gastrointestinal Hemo | 1963 |
Gastroprotection by vitamin C--a heme oxygenase-1-dependent mechanism?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Aspirin; Cell Line, Tumor; Dose-Response Rel | 2003 |
PPARgamma mediates NSAIDs-induced upregulation of TFF2 expression in gastric epithelial cells.
Topics: Anilides; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line, Tumor; Dose-Response Relation | 2004 |
[Helicobacter pylori: changes of indications for eradication therapy].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastroesophageal Reflu | 2004 |
Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism.
Topics: Apoptosis; Aspirin; Blotting, Western; Caspases; Cell Survival; DNA, Neoplasm; Dose-Response Relatio | 2004 |
Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer.
Topics: Apoptosis; Aspirin; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carrie | 2005 |
Low-dose aspirin affects the clinicopathological features of gastric cancer.
Topics: Aged; Aspirin; Case-Control Studies; Chi-Square Distribution; Female; Humans; Male; Neoplasm Staging | 2006 |
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Blotting, Western; Cell Sur | 2006 |
Aspirin-induced apoptosis in human gastric cancer epithelial cells: relationship with protein kinase C signaling.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspases; Cell Line, Tu | 2007 |
Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Cell Line, Tumor; C | 2008 |
Effects of sodium chloride, saccharin, phenobarbital and aspirin on gastric carcinogenesis in rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine.
Topics: Adenocarcinoma; Animals; Aspirin; Carcinogens; Male; Methylnitronitrosoguanidine; Phenobarbital; Rat | 1984 |
Cocarcinogenic action of aspirin on gastric tumors induced by N-nitroso-N-methylnitroguanidine in rats.
Topics: Adenocarcinoma; Animals; Aspirin; Carcinoma, Squamous Cell; Cocarcinogenesis; Female; Humans; Male; | 1983 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
Topics: Animals; Aspirin; FANFT; Male; Rats; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1984 |
Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate.
Topics: Adenocarcinoma; Animals; Aspirin; Cocarcinogenesis; Diet; Disease Models, Animal; Leiomyosarcoma; Ma | 1984 |
Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
Topics: Animals; Aspirin; Carcinogens; Cell Division; Epithelium; FANFT; Male; Rats; Rats, Inbred F344; Stom | 1984 |
Haematemesis and melaena in the elderly.
Topics: Aged; Alcohol Drinking; Anti-Inflammatory Agents; Aspirin; Esophagitis; Female; Gastritis; Hematemes | 1984 |
[Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Agents; Aspirin; Chromomycin A3; Dipyridamole; Female | 1982 |
Work in progress. Gastrointestinal ulcerations: detection using a technetium-99m-labeled ulcer-avid agent.
Topics: Aluminum; Animals; Aspirin; Barium Sulfate; Drug Evaluation; Endoscopy; Gastric Mucosa; Humans; Isot | 1983 |
Demonstration of a pH gradient across the mucus layer on the surface of human gastric mucosa in vitro.
Topics: Aspirin; Cystine; Gastric Mucosa; Humans; Hydrochloric Acid; Hydrogen-Ion Concentration; In Vitro Te | 1982 |
Effects of eicosanoid metabolism inhibitors on growth of a human gastric tumour cell line (HGT).
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Arachidonic Acid; Aspirin; Cell Divisi | 1993 |
Aspirin use and risk of fatal cancer.
Topics: Acetaminophen; Aspirin; Colonic Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Female; | 1993 |
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; | 1998 |
Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Blotting, Northern; Blotting, Western; | 1999 |
Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.
Topics: Adenocarcinoma; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, | 1999 |
Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability.
Topics: Adaptor Proteins, Signal Transducing; Aspirin; Base Pair Mismatch; Carrier Proteins; Cyclooxygenase | 1999 |
H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells.
Topics: Aspirin; Genes, Dominant; Helicobacter pylori; Humans; I-kappa B Kinase; I-kappa B Proteins; Interle | 2000 |
Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Ant | 2000 |
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; | 2001 |
Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; bcl-2 Homologous Antagonist-Killer Prot | 2001 |
[Lactate dehydrogenase (LDH) activity of the gastric juice depending on the metabolic state and protective barrier of the gastric mucosa].
Topics: Adult; Aspirin; Chronic Disease; Duodenal Ulcer; Enzyme Activation; Gastric Juice; Gastric Mucosa; G | 1978 |
Hour-glass stomach: an explanation.
Topics: Adult; Aged; Aspirin; Constriction, Pathologic; Female; Humans; Male; Middle Aged; Sex Factors; Stom | 1976 |
Drug-induced bleeding of gastric leiomyoma.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Humans; | 1987 |
The management of upper gastro-intestinal tract haemorrhage.
Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Aspirin; Carcinoma; Duodenal Ulcer; Esophageal and Gastric | 1973 |
Aspirin-induced haemorrhage in gastric leiomyoma.
Topics: Adult; Aspirin; Gastrointestinal Hemorrhage; Humans; Leiomyoma; Male; Radiography; Stomach Neoplasms | 1973 |
Cancer and upper gastrointestinal tract hemorrhage. Benign causes of bleeding demonstrated by endoscopy.
Topics: Acute Disease; Adenocarcinoma; Aspirin; Chronic Disease; Endoscopy; Esophageal and Gastric Varices; | 1973 |
Pyloric stenosis. A different approach to management.
Topics: Adult; Age Factors; Aged; Animals; Ascorbic Acid; Aspirin; Diet Therapy; Drainage; Female; Humans; I | 1973 |
Gastro-intestinal bleeding: the role of vitamin C.
Topics: Ascorbic Acid Deficiency; Aspirin; Feeding Behavior; Gastrointestinal Hemorrhage; Hernia, Diaphragma | 1969 |
[Apropos of 135 cases of massive gastroduodenal hemorrhage (portal hypertension excluded)].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cortisone; Endoscopy; Female; Gastritis; Gastrointestinal Hemo | 1968 |
Gastric ulcer, duodenal ulcer and gastric carcinoma: a case-control study of certain social and environmental factors.
Topics: Adult; Aged; Alcohol Drinking; Aspirin; Australia; Divorce; Duodenal Ulcer; Educational Status; Fami | 1968 |
[Pseudoneoplastic appearance of ulcer of medicamentous origin. Cure of hiatal hernia associated with the medical treatment].
Topics: Aspirin; Diagnosis, Differential; Female; Hernia, Diaphragmatic; Humans; Peptic Ulcer; Radiography; | 1968 |